Timothy L. Holman

1.2k total citations
22 papers, 896 citations indexed

About

Timothy L. Holman is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Timothy L. Holman has authored 22 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Timothy L. Holman's work include Schizophrenia research and treatment (7 papers), Hormonal and reproductive studies (6 papers) and Bipolar Disorder and Treatment (4 papers). Timothy L. Holman is often cited by papers focused on Schizophrenia research and treatment (7 papers), Hormonal and reproductive studies (6 papers) and Bipolar Disorder and Treatment (4 papers). Timothy L. Holman collaborates with scholars based in United States. Timothy L. Holman's co-authors include Del D. Miller, Paul J. Perry, Vicki L. Ellingrod, Stephan Arndt, Brian C. Lund, Jane S. Paulsen, Fergal J. Fleming, P. J. Perry, William R. Yates and P.F. Buckley and has published in prestigious journals such as Clinical Chemistry, Schizophrenia Research and The Journal of Clinical Psychiatry.

In The Last Decade

Timothy L. Holman

20 papers receiving 848 citations

Peers

Timothy L. Holman
Michael Haberhausen Germany
Frank Theisen Germany
Terri Sebree United States
Steve Mann Canada
Shoko Tsuchimine Japan
Natalie Freeman Canada
Karuna Jayathilake United States
Javier Vázquez-Bourgón Spain
Christo Minov Germany
Rosa Catalán Spain
Michael Haberhausen Germany
Timothy L. Holman
Citations per year, relative to Timothy L. Holman Timothy L. Holman (= 1×) peers Michael Haberhausen

Countries citing papers authored by Timothy L. Holman

Since Specialization
Citations

This map shows the geographic impact of Timothy L. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy L. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy L. Holman more than expected).

Fields of papers citing papers by Timothy L. Holman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy L. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy L. Holman. The network helps show where Timothy L. Holman may publish in the future.

Co-authorship network of co-authors of Timothy L. Holman

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy L. Holman. A scholar is included among the top collaborators of Timothy L. Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy L. Holman. Timothy L. Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellingrod, Vicki L., Del D. Miller, Brian C. Lund, et al.. (2025). 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia. Psychopharmacology Bulletin. 37(2). 109–112. 1 indexed citations
2.
Holman, Timothy L.. (2024). Creating Simple And Effective Prerecorded Web Based Lectures. Papers on Engineering Education Repository (American Society for Engineering Education). 4.150.1–4.150.7.
3.
Bishop, Jeffrey R., Del D. Miller, Vicki L. Ellingrod, & Timothy L. Holman. (2011). Association between type‐three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia. Human Psychopharmacology Clinical and Experimental. 26(1). 28–34. 22 indexed citations
4.
Kuperman, Samuel, et al.. (2011). An Open-Label Trial of Aripiprazole in the Treatment of Aggression in Male Adolescents Diagnosed with Conduct Disorder. Annals of Clinical Psychiatry. 23(4). 270–276. 8 indexed citations
5.
Argo, Tami R., Ryan M. Carnahan, Mitchell J. Barnett, Timothy L. Holman, & Paul J. Perry. (2011). Diabetes Prevalence Estimates in Schizophrenia and Risk Factor Assessment. Annals of Clinical Psychiatry. 23(2). 117–124. 14 indexed citations
6.
Ellingrod, Vicki L., Del D. Miller, Stephan F. Taylor, et al.. (2008). Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophrenia Research. 98(1-3). 47–54. 89 indexed citations
7.
Miller, Del D., Vicki L. Ellingrod, Timothy L. Holman, P.F. Buckley, & Stephan Arndt. (2005). Clozapine‐induced weight gain associated with the 5HT2C receptor −759C/T polymorphism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 133B(1). 97–100. 116 indexed citations
8.
Ellingrod, Vicki L., Paul J. Perry, John C. Ringold, et al.. (2005). Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapine. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 134B(1). 76–78. 112 indexed citations
9.
Perry, Paul J., Tami R. Argo, Ryan M. Carnahan, et al.. (2005). The Association of Weight Gain and Olanzapine Plasma Concentrations. Journal of Clinical Psychopharmacology. 25(3). 250–254. 42 indexed citations
10.
Perry, Paul J., William R. Yates, Richard D. Williams, et al.. (2002). Testosterone Therapy in Late-Life Major Depression in Males. The Journal of Clinical Psychiatry. 63(12). 1096–1101. 60 indexed citations
11.
Perry, Paul J., Brian C. Lund, Stephan Arndt, et al.. (2001). Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy.. Annals of Clinical Psychiatry. 13(2). 75–80. 45 indexed citations
12.
Kuperman, S., Paul J. Perry, Gary Gaffney, et al.. (2001). Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.. Annals of Clinical Psychiatry. 13(3). 129–134. 68 indexed citations
13.
Perry, Paul J., Brian C. Lund, Stephan Arndt, et al.. (2001). Bioavailable Testosterone as a Correlate of Cognition, Psychological Status, Quality of Life, and Sexual Function in Aging Males: Implications for Testosterone Replacement Therapy. Annals of Clinical Psychiatry. 13(2). 75–80. 39 indexed citations
14.
Kuperman, Samuel, Paul J. Perry, Gary Gaffney, et al.. (2001). Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults. Annals of Clinical Psychiatry. 13(3). 129–134. 61 indexed citations
15.
MacIndoe, John H., Paul J. Perry, William R. Yates, et al.. (1997). Testosterone Suppression of the HPT Axis. Journal of Investigative Medicine. 45(8). 441–447. 42 indexed citations
16.
Ellingrod, Vicki L., Paul J. Perry, William R. Yates, et al.. (1997). The Effects of Anabolic Steroids on Driving Performance as Assessed by the Iowa Driver Simulator. The American Journal of Drug and Alcohol Abuse. 23(4). 623–636. 16 indexed citations
17.
Perry, Paul J., John H. MacIndoe, William R. Yates, Shannon D. Scott, & Timothy L. Holman. (1997). Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone. Clinical Chemistry. 43(5). 731–735. 26 indexed citations
18.
Miller, Del D., Fergal J. Fleming, Timothy L. Holman, & P. J. Perry. (1994). Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.. PubMed. 55 Suppl B. 117–21. 96 indexed citations
19.
Perry, Paul J., Del D. Miller, Stephan Arndt, Daniel A. Smith, & Timothy L. Holman. (1993). Haloperidol Dosing Requirements. Journal of Clinical Psychopharmacology. 13(1). 46???51–46???51. 30 indexed citations
20.
Murry, Daryl J., et al.. (1992). Performance in a Clinical Pharmacy Clerkship: Computer-Aided Instruction Versus Traditional Lectures. American Journal of Pharmaceutical Education. 56(3). 259–263. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Haberhausen Breakdown of academic impact, for papers by Frank Theisen Breakdown of academic impact, for papers by Terri Sebree Breakdown of academic impact, for papers by Steve Mann Breakdown of academic impact, for papers by Shoko Tsuchimine Breakdown of academic impact, for papers by Natalie Freeman Breakdown of academic impact, for papers by Karuna Jayathilake Breakdown of academic impact, for papers by Javier Vázquez-Bourgón Breakdown of academic impact, for papers by Christo Minov Breakdown of academic impact, for papers by Rosa Catalán
Rankless by CCL
2026